Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2011, Article ID 345803, 12 pages
http://dx.doi.org/10.1155/2011/345803
Review Article

Role of IL-17 and Th17 Cells in Liver Diseases

Department of Medicine III, RWTH-University Hospital Aachen, Pauwelsstraße 30, 52074 Aachen, Germany

Received 31 August 2010; Revised 3 October 2010; Accepted 3 October 2010

Academic Editor: T. Nakayama

Copyright © 2011 Linda Hammerich et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Tacke, T. Luedde, and C. Trautwein, “Inflammatory pathways in liver homeostasis and liver injury,” Clinical Reviews in Allergy and Immunology, vol. 36, no. 1, pp. 4–12, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. K. Wallace, A. D. Burt, and M. C. Wright, “Liver fibrosis,” Biochemical Journal, vol. 411, no. 1, pp. 1–18, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. K. R. Karlmark, R. Weiskirchen, and R. Weiskirchen, “Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis,” Hepatology, vol. 50, no. 1, pp. 261–274, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. H. W. Zimmermann, S. Seidler, and S. Seidler, “Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis,” PloS One, vol. 5, no. 6, Article ID e11049, 2010. View at Publisher · View at Google Scholar · View at PubMed
  5. V. Racanelli and B. Rehermann, “The liver as an immunological organ,” Hepatology, vol. 43, no. 2, supplement 1, pp. S54–S62, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. I. N. Crispe, “The liver as a lymphoid organ,” Annual Review of Immunology, vol. 27, pp. 147–163, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. T. R. Mosmann, H. Cherwinski, and M. W. Bond, “Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins,” Journal of Immunology, vol. 136, no. 7, pp. 2348–2357, 1986. View at Google Scholar · View at Scopus
  8. L. H. Glimcher and K. M. Murphy, “Lineage commitment in the immune system: the T helper lymphocyte grows up,” Genes and Development, vol. 14, no. 14, pp. 1693–1711, 2000. View at Google Scholar · View at Scopus
  9. K. M. Murphy and S. L. Reiner, “The lineage decisions of helper T cells,” Nature Reviews Immunology, vol. 2, no. 12, pp. 933–944, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. A. O'Garra and N. Arai, “The molecular basis of T helper 1 and T helper 2 cell differentiation,” Trends in Cell Biology, vol. 10, no. 12, pp. 542–550, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. W.-P. Zheng and R. A. Flavell, “The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells,” Cell, vol. 89, no. 4, pp. 587–596, 1997. View at Google Scholar · View at Scopus
  12. S. Sakaguchi, “Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses,” Annual Review of Immunology, vol. 22, pp. 531–562, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. W. Chen, W. Jin, and W. Jin, “Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3,” Journal of Experimental Medicine, vol. 198, no. 12, pp. 1875–1886, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. M. O. Li, S. Sanjabi, and R. Flavell, “Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms,” Immunity, vol. 25, no. 3, pp. 455–471, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. J. D. Fontenot, M. A. Gavin, and A. Y. Rudensky, “Foxp3 programs the development and function of CD4+CD25+ regulatory T cells,” Nature Immunology, vol. 4, no. 4, pp. 330–336, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger, “TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells,” Immunity, vol. 24, no. 2, pp. 179–189, 2006. View at Publisher · View at Google Scholar · View at PubMed
  17. M. Veldhoen and B. Stockinger, “TGFβ1, a 'Jack of all trades': the link with pro-inflammatory IL-17-producing T cells,” Trends in Immunology, vol. 27, no. 8, pp. 358–361, 2006. View at Publisher · View at Google Scholar · View at PubMed
  18. N. J. Wilson, K. Boniface, and K. Boniface, “Development, cytokine profile and function of human interleukin 17-producing helper T cells,” Nature Immunology, vol. 8, no. 9, pp. 950–957, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. E. V. Acosta-Rodriguez, G. Napolitani, A. Lanzavecchia, and F. Sallusto, “Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells,” Nature Immunology, vol. 8, no. 9, pp. 942–949, 2007. View at Publisher · View at Google Scholar · View at PubMed
  20. E. Volpe, N. Servant, R. Zollinger, S. I. Bogiatzi, P. Hupé, E. Barillot, and V. Soumelis, “A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses,” Nature Immunology, vol. 9, no. 6, pp. 650–657, 2008. View at Publisher · View at Google Scholar · View at PubMed
  21. I. I. Ivanov, B. S. McKenzie, and B. S. McKenzie, “The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells,” Cell, vol. 126, no. 6, pp. 1121–1133, 2006. View at Publisher · View at Google Scholar · View at PubMed
  22. X. O. Yang, A. D. Panopoulos, R. Nurieva, H. C. Seon, D. Wang, S. S. Watowich, and C. Dong, “STAT3 regulates cytokine-mediated generation of inflammatory helper T cells,” Journal of Biological Chemistry, vol. 282, no. 13, pp. 9358–9363, 2007. View at Publisher · View at Google Scholar · View at PubMed
  23. X. O. Yang, B. P. Pappu, and B. P. Pappu, “T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORαα and RORγ,” Immunity, vol. 28, no. 1, pp. 29–39, 2008. View at Publisher · View at Google Scholar · View at PubMed
  24. P. R. Mangan, L. E. Harrington, and L. E. Harrington, “Transforming growth factor-β induces development of the T H17 lineage,” Nature, vol. 441, no. 7090, pp. 231–234, 2006. View at Publisher · View at Google Scholar · View at PubMed
  25. L. E. Harrington, P. R. Mangan, and C. T. Weaver, “Expanding the effector CD4 T-cell repertoire: the Th17 lineage,” Current Opinion in Immunology, vol. 18, no. 3, pp. 349–356, 2006. View at Publisher · View at Google Scholar · View at PubMed
  26. C. L. Langrish, Y. Chen, and Y. Chen, “IL-23 drives a pathogenic T cell population that induces autoimmune inflammation,” Journal of Experimental Medicine, vol. 201, no. 2, pp. 233–240, 2005. View at Publisher · View at Google Scholar · View at PubMed
  27. W. Ouyang, J. K. Kolls, and Y. Zheng, “The biological functions of T helper 17 cell effector cytokines in inflammation,” Immunity, vol. 28, no. 4, pp. 454–467, 2008. View at Publisher · View at Google Scholar · View at PubMed
  28. C. Dong, “Regulation and pro-inflammatory function of interleukin-17 family cytokines,” Immunological Reviews, vol. 226, no. 1, pp. 80–86, 2008. View at Publisher · View at Google Scholar · View at PubMed
  29. C. E. Jones and K. Chan, “Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-α, and granulocyte-colony-stimulating factor by human airway epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 26, no. 6, pp. 748–753, 2002. View at Google Scholar
  30. P. Ye, F. H. Rodriguez, and F. H. Rodriguez, “Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense,” Journal of Experimental Medicine, vol. 194, no. 4, pp. 519–527, 2001. View at Publisher · View at Google Scholar
  31. T. Sparna, J. Rétey, and J. Rétey, “Genome-wide comparison between IL-17 and combined TNF-alpha/IL-17 induced genes in primary murine hepatocytes,” BMC Genomics, vol. 11, no. 1, 2010. View at Publisher · View at Google Scholar · View at PubMed
  32. D. N. Patel, C. A. King, and C. A. King, “Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-κB and C/EBPβ activation,” Journal of Biological Chemistry, vol. 282, no. 37, pp. 27229–27238, 2007. View at Publisher · View at Google Scholar · View at PubMed
  33. K. Harada, S. Shimoda, Y. Sato, K. Isse, H. Ikeda, and Y. Nakanuma, “Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis,” Clinical and Experimental Immunology, vol. 157, no. 2, pp. 261–270, 2009. View at Publisher · View at Google Scholar · View at PubMed
  34. A. Puel, R. Döffinger, and R. Döffinger, “Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I,” Journal of Experimental Medicine, vol. 207, no. 2, pp. 291–297, 2010. View at Publisher · View at Google Scholar · View at PubMed
  35. K. Kisand, A. S. Bøe Wolff, and A. S. Bøe Wolff, “Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines,” Journal of Experimental Medicine, vol. 207, no. 2, pp. 299–308, 2010. View at Publisher · View at Google Scholar · View at PubMed
  36. K. Atarashi, J. Nishimura, and J. Nishimura, “ATP drives lamina propria TH17 cell differentiation,” Nature, vol. 455, no. 7214, pp. 808–812, 2008. View at Publisher · View at Google Scholar · View at PubMed
  37. D. J. Cua, J. Sherlock, and J. Sherlock, “Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain,” Nature, vol. 421, no. 6924, pp. 744–748, 2003. View at Publisher · View at Google Scholar · View at PubMed
  38. Y. Komiyama, S. Nakae, and S. Nakae, “IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis,” Journal of Immunology, vol. 177, no. 1, pp. 566–573, 2006. View at Google Scholar
  39. J. Pène, S. Chevalier, and S. Chevalier, “Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes,” Journal of Immunology, vol. 180, no. 11, pp. 7423–7430, 2008. View at Google Scholar
  40. R. H. Duerr, K. D. Taylor, and K. D. Taylor, “A genome-wide association study identifies IL23R as an inflammatory bowel disease gene,” Science, vol. 314, no. 5804, pp. 1461–1463, 2006. View at Publisher · View at Google Scholar · View at PubMed
  41. G. Tiegs, J. Hentschel, and A. Wendel, “A T cell-dependent experimental liver injury in mice inducible by concanavalin A,” Journal of Clinical Investigation, vol. 90, no. 1, pp. 196–203, 1992. View at Google Scholar
  42. G. Tiegs, “Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury,” Zeitschrift fur Gastroenterologie, vol. 45, no. 1, pp. 63–70, 2007. View at Publisher · View at Google Scholar · View at PubMed
  43. T. Nagata, L. McKinley, J. J. Peschon, J. F. Alcorn, S. J. Aujla, and J. K. Kolls, “Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells,” Journal of Immunology, vol. 181, no. 11, pp. 7473–7479, 2008. View at Google Scholar
  44. F. Hong, B. Jaruga, and B. Jaruga, “Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS,” Journal of Clinical Investigation, vol. 110, no. 10, pp. 1503–1513, 2002. View at Publisher · View at Google Scholar
  45. B. Jaruga, F. Hong, R. Sun, S. Radaeva, and B. Gao, “Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes,” Journal of Immunology, vol. 171, no. 6, pp. 3233–3244, 2003. View at Google Scholar
  46. L. A. Zenewicz, G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, M. Karow, and R. A. Flavell, “Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation,” Immunity, vol. 27, no. 4, pp. 647–659, 2007. View at Publisher · View at Google Scholar · View at PubMed
  47. F. Lafdil, H. Wang, and H. Wang, “Myeloid STAT3 Inhibits T Cell-Mediated Hepatitis by Regulating T Helper 1 Cytokine and Interleukin-17 Production,” Gastroenterology, vol. 137, no. 6, article e2, pp. 2125–2135, 2009. View at Publisher · View at Google Scholar · View at PubMed
  48. R. Sun, O. Park, and O. Park, “STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice,” Hepatology, vol. 44, no. 4, pp. 955–966, 2006. View at Publisher · View at Google Scholar · View at PubMed
  49. E. J. Pearce and A. S. MacDonald, “The immunobiology of schistosomiasis,” Nature Reviews Immunology, vol. 2, no. 7, pp. 499–511, 2002. View at Google Scholar
  50. W. C. Gause, J. F. Urban Jr., and M. J. Stadecker, “The immune response to parasitic helminths: insights from murine models,” Trends in Immunology, vol. 24, no. 5, pp. 269–277, 2003. View at Publisher · View at Google Scholar
  51. L. I. Rutitzky, H. J. Hernandez, and M. J. Stadecker, “Th1-polarizing immunization with egg antigens correlates with severe exarcebation of immunopathology and death in schistosome infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 23, pp. 13243–13248, 2001. View at Publisher · View at Google Scholar · View at PubMed
  52. L. I. Rutitzky, P. M. Smith, and M. J. Stadecker, “T-bet protects against exacerbation of schistosome egg-induced immunopathology by regulating Th17-mediated inflammation,” European Journal of Immunology, vol. 39, no. 9, pp. 2470–2481, 2009. View at Publisher · View at Google Scholar · View at PubMed
  53. L. I. Rutitzky, L. Bazzone, M. G. Shainheit, B. Joyce-Shaikh, D. J. Cua, and M. J. Stadecker, “IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17,” Journal of Immunology, vol. 180, no. 4, pp. 2486–2495, 2008. View at Google Scholar
  54. L. I. Rutitzky, J. R. Lopes da Rosa, and M. J. Stadecker, “Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17,” Journal of Immunology, vol. 175, no. 6, pp. 3920–3926, 2005. View at Google Scholar
  55. M. Umemura, A. Yahagi, and A. Yahagi, “IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guérin infection,” Journal of Immunology, vol. 178, no. 6, pp. 3786–3796, 2007. View at Google Scholar
  56. E. Lockhart, A. M. Green, and J. L. Flynn, “IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection,” Journal of Immunology, vol. 177, no. 7, pp. 4662–4669, 2006. View at Google Scholar
  57. S. Hamada, M. Umemura, and M. Umemura, “IL-17A produced by γδ T cells plays a critical role in innate immunity against Listeria monocytogenes infection in the liver,” Journal of Immunology, vol. 181, no. 5, pp. 3456–3463, 2008. View at Google Scholar
  58. T. L. Salunga, Z.-G. Cui, and Z.-G. Cui, “Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis,” Journal of Autoimmunity, vol. 29, no. 2-3, pp. 78–86, 2007. View at Publisher · View at Google Scholar · View at PubMed
  59. I. R. Mackay, S. Whittingham, S. Fida, M. Myers, N. Ikuno, M. E. Gershwin, and M. J. Rowley, “The peculiar autoimmunity of primary biliary cirrhosis,” Immunological Reviews, vol. 174, pp. 226–237, 2000. View at Publisher · View at Google Scholar
  60. K. Wakabayashi, Z.-X. Lian, and Z.-X. Lian, “IL-2 receptor α(-/-) mice and the development of primary biliary cirrhosis,” Hepatology, vol. 44, no. 5, pp. 1240–1249, 2006. View at Publisher · View at Google Scholar · View at PubMed
  61. A. Laurence, C. M. Tato, and C. M. Tato, “Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation,” Immunity, vol. 26, no. 3, pp. 371–381, 2007. View at Publisher · View at Google Scholar · View at PubMed
  62. R. Y. Z. Lan, T. L. Salunga, and T. L. Salunga, “Hepatic IL-17 responses in human and murine primary biliary cirrhosis,” Journal of Autoimmunity, vol. 32, no. 1, pp. 43–51, 2009. View at Publisher · View at Google Scholar · View at PubMed
  63. Q. You, L. Cheng, T. P. Reilly, D. Wegmann, and C. Ju, “Role of neutrophils in a mouse model of halothane-induced liver injury,” Hepatology, vol. 44, no. 6, pp. 1421–1431, 2006. View at Publisher · View at Google Scholar · View at PubMed
  64. E. Kobayashi, M. Kobayashi, K. Tsuneyama, T. Fukami, M. Nakajima, and T. Yokoi, “Halothane-induced liver injury is mediated by interleukin-17 in mice,” Toxicological Sciences, vol. 111, no. 2, pp. 302–310, 2009. View at Publisher · View at Google Scholar · View at PubMed
  65. P. E. Molina, C. McClain, D. Valla, D. Guidot, A. M. Diehl, C. H. Lang, and M. Neuman, “Molecular pathology and clinical aspects of alcohol-induced tissue injury,” Alcoholism: Clinical and Experimental Research, vol. 26, no. 1, pp. 120–128, 2002. View at Google Scholar
  66. S. W. French, J. Nash, P. Shitabata et al., “Pathology of alcoholic liver disease. VA Cooperative Study Group 119,” Seminars in Liver Disease, vol. 13, no. 2, pp. 154–169, 1993. View at Google Scholar
  67. C. S. Lieber, “Alcoholic liver disease: new insights in pathogenesis lead to new treatments,” Journal of Hepatology, vol. 32, no. 1, supplement, pp. 113–128, 2000. View at Google Scholar
  68. R. G. Batey and J. Wang, “Molecular pathogenesis of T lymphocyte-induced liver injury in alcoholic hepatitis,” Front Biosci, vol. 7, pp. d1662–1675, 2002. View at Google Scholar
  69. S. Natori, C. Rust, L. M. Stadheim, A. Srinivasan, L. J. Burgart, and G. J. Gores, “Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis,” Journal of Hepatology, vol. 34, no. 2, pp. 248–253, 2001. View at Publisher · View at Google Scholar
  70. H. Jaeschke, “Neutrophil-mediated tissue injury in alcoholic hepatitis,” Alcohol, vol. 27, no. 1, pp. 23–27, 2002. View at Publisher · View at Google Scholar
  71. A. Lemmers, C. Moreno, and C. Moreno, “The interleukin-17 pathway is involved in human alcoholic liver disease,” Hepatology, vol. 49, no. 2, pp. 646–657, 2009. View at Publisher · View at Google Scholar · View at PubMed
  72. M. Marí, F. Caballero, and F. Caballero, “Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis,” Cell Metabolism, vol. 4, no. 3, pp. 185–198, 2006. View at Publisher · View at Google Scholar · View at PubMed
  73. J. K. Reddy and M. S. Rao, “Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 290, no. 5, pp. G852–G858, 2006. View at Publisher · View at Google Scholar · View at PubMed
  74. S. G. Hübscher, “Histological assessment of non-alcoholic fatty liver disease,” Histopathology, vol. 49, no. 5, pp. 450–465, 2006. View at Publisher · View at Google Scholar · View at PubMed
  75. N. G. Sandler, M. M. Mentink-Kane, A. W. Cheever, and T. A. Wynn, “Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair,” Journal of Immunology, vol. 171, no. 7, pp. 3655–3667, 2003. View at Google Scholar
  76. I. R. Wanless and K. Shiota, “The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis,” Seminars in Liver Disease, vol. 24, no. 1, pp. 99–106, 2004. View at Publisher · View at Google Scholar · View at PubMed
  77. A. G. Rowan, J. M. Fletcher, E. J. Ryan, B. Moran, J. E. Hegarty, C. O'Farrelly, and K. H. G. Mills, “Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-β,” Journal of Immunology, vol. 181, no. 7, pp. 4485–4494, 2008. View at Google Scholar
  78. J. Y. Zhang, Z. Zhang, F. S. Wang et al., “Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B,” Hepatology, vol. 51, no. 1, pp. 81–91, 2010. View at Google Scholar
  79. M. A. Jimenez-Sousa, R. Almansa, and R. Almansa, “Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin,” European Cytokine Network, vol. 21, no. 2, pp. 84–91, 2010. View at Publisher · View at Google Scholar · View at PubMed
  80. W. Hou, H. S. Kang, and B. S. Kim, “Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection,” Journal of Experimental Medicine, vol. 206, no. 2, pp. 313–328, 2009. View at Publisher · View at Google Scholar · View at PubMed
  81. J.-P. Zhang, J. Yan, and J. Yan, “Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients,” Journal of Hepatology, vol. 50, no. 5, pp. 980–989, 2009. View at Publisher · View at Google Scholar · View at PubMed
  82. D.-M. Kuang, C. Peng, Q. Zhao, Y. Wu, M.-S. Chen, and L. Zheng, “Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells,” Hepatology, vol. 51, no. 1, pp. 154–164, 2010. View at Publisher · View at Google Scholar · View at PubMed
  83. J. L. Langowski, R. A. Kastelein, and M. Oft, “Swords into plowshares: IL-23 repurposes tumor immune surveillance,” Trends in Immunology, vol. 28, no. 5, pp. 207–212, 2007. View at Publisher · View at Google Scholar · View at PubMed
  84. J. L. Langowski, X. Zhang, and X. Zhang, “IL-23 promotes tumour incidence and growth,” Nature, vol. 442, no. 7101, pp. 461–465, 2006. View at Publisher · View at Google Scholar · View at PubMed
  85. M. Numasaki, J.-I. Fukushi, and J.-I. Fukushi, “Interleukin-17 promotes angiogenesis and tumor growth,” Blood, vol. 101, no. 7, pp. 2620–2627, 2003. View at Publisher · View at Google Scholar · View at PubMed
  86. G. Rong, Y. Zhou, and Y. Zhou, “Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population,” Clinical and Experimental Immunology, vol. 156, no. 2, pp. 217–225, 2009. View at Publisher · View at Google Scholar · View at PubMed
  87. E. Fábrega, M. López-Hoyos, D. San Segundo, F. Casafont, and F. Pons-Romero, “Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation,” Liver Transplantation, vol. 15, no. 6, pp. 629–633, 2009. View at Publisher · View at Google Scholar · View at PubMed
  88. D. Vergani and G. Mieli-Vergani, “Aetiopathogenesis of autoimmune hepatitis,” World Journal of Gastroenterology, vol. 14, no. 21, pp. 3306–3312, 2008. View at Publisher · View at Google Scholar
  89. Y. Yasumi, Y. Takikawa, R. Endo, and K. Suzuki, “Interleukin-17 as a new marker of severity of acute hepatic injury,” Hepatology Research, vol. 37, no. 4, pp. 248–254, 2007. View at Publisher · View at Google Scholar · View at PubMed
  90. Y. H. Oo and D. H. Adams, “The role of chemokines in the recruitment of lymphocytes to the liver,” Journal of Autoimmunity, vol. 34, no. 1, pp. 45–54, 2010. View at Publisher · View at Google Scholar · View at PubMed
  91. F. Sallusto, A. Lanzavecchia, and C. R. MacKay, “Chemokines and chemokine receptors in T-cell priming and Th1/Th2- mediated responses,” Immunology Today, vol. 19, no. 12, pp. 568–574, 1998. View at Publisher · View at Google Scholar
  92. C. R. Mackay, “Chemokines: immunology's high impact factors,” Nature Immunology, vol. 2, no. 2, pp. 95–101, 2001. View at Publisher · View at Google Scholar · View at PubMed
  93. F. Sallusto, C. R. Mackay, and A. Lanzavecchia, “The role of chemokine receptors in primary, effector, and memory immune responses,” Annual Review of Immunology, vol. 18, pp. 593–620, 2000. View at Publisher · View at Google Scholar · View at PubMed
  94. P. Gao, X.-Y. Zhou, and X.-Y. Zhou, “The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3,” Journal of Leukocyte Biology, vol. 73, no. 2, pp. 273–280, 2003. View at Publisher · View at Google Scholar
  95. F. Sallusto, D. Lenig, C. R. Mackay, and A. Lanzavecchia, “Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes,” Journal of Experimental Medicine, vol. 187, no. 6, pp. 875–883, 1998. View at Publisher · View at Google Scholar
  96. T. Kawai, M. Seki, and M. Seki, “Selective diapedesis of Th1 cells induced by endothelial cell RANTES,” Journal of Immunology, vol. 163, no. 6, pp. 3269–3278, 1999. View at Google Scholar
  97. A. R. Glabinski, B. Bielecki, S. O'Bryant, K. Selmaj, and R. M. Ransohoff, “Experimental autoimmune encephalomyelitis: CC chemokine receptor expression by trafficking cells,” Journal of Autoimmunity, vol. 19, no. 4, pp. 175–181, 2002. View at Publisher · View at Google Scholar
  98. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati, “The chemokine system in diverse forms of macrophage activation and polarization,” Trends in Immunology, vol. 25, no. 12, pp. 677–686, 2004. View at Publisher · View at Google Scholar · View at PubMed
  99. R. Bonecchi, G. Bianchi, and G. Bianchi, “Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s,” Journal of Experimental Medicine, vol. 187, no. 1, pp. 129–134, 1998. View at Publisher · View at Google Scholar
  100. H. E. Wasmuth, F. Tacke, and C. Trautwein, “Chemokines in liver inflammation and fibrosis,” Seminars in Liver Disease, vol. 30, no. 3, pp. 215–225, 2010. View at Publisher · View at Google Scholar · View at PubMed
  101. T. Yamazaki, X. O. Yang, and X. O. Yang, “CCR6 regulates the migration of inflammatory and regulatory T cells,” Journal of Immunology, vol. 181, no. 12, pp. 8391–8401, 2008. View at Google Scholar
  102. B. Eksteen, A. E. Miles, A. J. Grant, and D. H. Adams, “Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease,” Clinical Medicine, vol. 4, no. 2, pp. 173–180, 2004. View at Google Scholar
  103. D. H. Adams and B. Eksteen, “Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease,” Nature Reviews Immunology, vol. 6, no. 3, pp. 244–251, 2006. View at Publisher · View at Google Scholar · View at PubMed
  104. K. Hirota, H. Yoshitomi, and H. Yoshitomi, “Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model,” Journal of Experimental Medicine, vol. 204, no. 12, pp. 2803–2812, 2007. View at Publisher · View at Google Scholar · View at PubMed
  105. Y. H. Oo, C. J. Weston, and C. J. Weston, “Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver,” Journal of Immunology, vol. 184, no. 6, pp. 2886–2898, 2010. View at Publisher · View at Google Scholar · View at PubMed
  106. C. T. Weaver and R. D. Hatton, “Interplay between the TH 17 and TReg cell lineages: a (co-)evolutionary perspective,” Nature Reviews Immunology, vol. 9, no. 12, pp. 883–889, 2009. View at Publisher · View at Google Scholar · View at PubMed
  107. C. Wang, S. G. Kang, J. Lee, Z. Sun, and C. H. Kim, “The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut,” Mucosal Immunology, vol. 2, no. 2, pp. 173–183, 2009. View at Publisher · View at Google Scholar · View at PubMed
  108. C. H. Kim, “Migration and function of Th17 cells,” Inflammation and Allergy—Drug Targets, vol. 8, no. 3, pp. 221–228, 2009. View at Google Scholar
  109. E. G. Harper, C. Guo, and C. Guo, “Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis,” Journal of Investigative Dermatology, vol. 129, no. 9, pp. 2175–2183, 2009. View at Publisher · View at Google Scholar · View at PubMed
  110. K. Shah, W. W. Lee, S. H. Lee, S. H. Kim, S. W. Kang, J. Craft, and I. Kang, “Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus,” Arthritis research & therapy, vol. 12, no. 2, p. R53, 2010. View at Google Scholar
  111. J.-E. Turner, H.-J. Paust, and H.-J. Paust, “CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis,” Journal of the American Society of Nephrology, vol. 21, no. 6, pp. 974–985, 2010. View at Publisher · View at Google Scholar · View at PubMed
  112. T. Kuwabara, F. Ishikawa, and F. Ishikawa, “CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells,” Journal of Immunology, vol. 183, no. 4, pp. 2513–2521, 2009. View at Publisher · View at Google Scholar · View at PubMed
  113. T. Inozume, K.-I. Hanada, Q. J. Wang, and J. C. Yang, “IL-17 secreted by tumor reactive T cells induces IL-8 release by human renal cancer cells,” Journal of Immunotherapy, vol. 32, no. 2, pp. 109–117, 2009. View at Publisher · View at Google Scholar · View at PubMed
  114. Z. Zhang, W. Zhong, D. Spencer, H. Chen, H. Lu, T. Kawaguchi, and J. T. Rosenbaum, “Interleukin-17 causes neutrophil mediated inflammation in ovalbumin-induced uveitis in DO11.10 mice,” Cytokine, vol. 46, no. 1, pp. 79–91, 2009. View at Publisher · View at Google Scholar · View at PubMed
  115. J. E. Turner, H. J. Paust, O. M. Steinmetz, and U. Panzer, “The Th17 immune response in renal inflammation,” Kidney International, vol. 77, no. 12, pp. 1070–1075, 2010. View at Publisher · View at Google Scholar · View at PubMed
  116. M. Pelletier, L. Maggi, and L. Maggi, “Evidence for a cross-talk between human neutrophils and Th17 cells,” Blood, vol. 115, no. 2, pp. 335–343, 2010. View at Publisher · View at Google Scholar · View at PubMed
  117. H. W. Lim, J. Lee, P. Hillsamer, and C. H. Kim, “Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells,” Journal of Immunology, vol. 180, no. 1, pp. 122–129, 2008. View at Google Scholar
  118. K. L. Streetz, F. Tacke, and F. Tacke, “Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases,” Hepatology, vol. 38, no. 1, pp. 218–229, 2003. View at Publisher · View at Google Scholar · View at PubMed